Skip to main content

Advertisement

SpringerLink
Log in

Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots

  • Review Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

Postmenopausal osteoporosis (PMOP) has already become a major public health problem. However, there was no bibliometric analysis estimating the evolutionary process of PMOP research.

Purpose

This study aimed to assess its scientific activity.

Methods

Publications on PMOP were retrieved from Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 2008 to 2018. VOSviewer software was used for data mining and visualization. The quantity of papers, number of citations, citation frequency per year, and H-index were assessed and compared among different countries, institutes, and researchers.

Results

A total of 11,142 papers were included and were cited 184,416 times. The USA contributed the most papers (3162), the most citations (83,270 times), and the highest H-index (115). Canada ranked first for the number of papers per million populations and per trillion GDP. Seven of the top ten funding agencies were industries. The key words were stratified into four clusters: cluster 1 (“basic research”), cluster 2 (“diagnosis”), cluster 3 (“treatment”), and cluster 4 (“others”). Average appearing years (AAY) of key words in cluster 1 were the largest compared to those in clusters 2 and 3. For hotspots, “miRNA” showed a relatively latest AAY of 2017.63, followed by “abaloparatide” and “adipokine”.

Conclusion

We concluded that the USA and Europe were the most productive regions on PMOP, with a high prevalence of articles supported by pharmaceutical companies. Key word focus gradually shifted from “diagnosis” to “treatment” and then to precision medicine orientated “basic research”. It is recommended to pay attention to potential research hotspots, such as “miRNA,” “abaloparatide,” and “adipokine”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

PMOP :

postmenopausal osteoporosis

SCI-E :

science citation index-expanded

WoS :

web of science

GDP :

gross domestic product

IF :

impact factor

AAY :

average appearing years

RCT :

randomized controlled trial

BMD :

bone mineral density

FRAX :

fracture risk assessment tool

References

  1. Kanis JA, EV MC, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O, Osteoarthritis, the Committee of Scientific Advisors of the International Osteoporosis F (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57

    Article  CAS  Google Scholar 

  2. Black DM, Rosen CJ (2016) Clinical Practice Postmenopausal Osteoporosis. N Engl J Med 374:254–262

    Article  CAS  Google Scholar 

  3. Imai T, Tanaka S, Kawakami K, Miyazaki T, Hagino H, Shiraki M, Group ATR (2017) Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial. Osteoporos Int 28:1893–1901

    Article  CAS  Google Scholar 

  4. Biglu MH, Ghavami M, Biglu S (2014) Authorship, institutional and citation metrics for publications on postmenopausal osteoporosis. Osteoporos Int 25:1337–1343

    Article  CAS  Google Scholar 

  5. Chen X, Zhi X, Cao L, Weng W, Pan P, Hu H, Liu C, Zhao Q, Zhou Q, Cui J, Su J (2017) Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis. Cell Death Dis 8:e3037

    Article  Google Scholar 

  6. Si L, Winzenberg TM, Chen M, Jiang Q, Neil A, Palmer AJ (2016) Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study. Osteoporos Int 27:2259–2269

    Article  CAS  Google Scholar 

  7. Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS, Eastell R (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27:21–31

    Article  CAS  Google Scholar 

  8. Glanville J, Kendrick T, McNally R, Campbell J, Hobbs FD (2011) Research output on primary care in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States: bibliometric analysis. Bmj 342:d1028

    Article  Google Scholar 

  9. Bornmann L, Leydesdorff L (2014) Scientometrics in a changing research landscape: bibliometrics has become an integral part of research quality evaluation and has been changing the practice of research. EMBO Rep 15:1228–1232

    Article  CAS  Google Scholar 

  10. Avcu G, Sahbudak Bal Z, Duyu M, Akkus E, Karapinar B, Vardar F (2015) Thanks to trauma: a delayed diagnosis of Pott disease. Pediatr Emerg Care 31:e17–e18

    Article  Google Scholar 

  11. Zhao J, Yu G, Cai M, Lei X, Yang Y, Wang Q, Zhai X (2018) Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus. Stem Cell Res Ther 9:32

    Article  Google Scholar 

  12. Gao Y, Wang Y, Zhai X, He Y, Chen R, Zhou J, Li M, Wang Q (2017) Publication trends of research on diabetes mellitus and T cells (1997-2016): a 20-year bibliometric study. PLoS One 12:e0184869

    Article  Google Scholar 

  13. Yiran W, Qijin W, Xianzhao W, et al. (2017) Global scientific trends on exosome research during 2007-2016: a bibliometric analysis. Oncotarget

  14. Wang Y, Wang Q, Zhu R, Yang C, Chen Z, Bai Y, Li M, Zhai X (2016) Trends of spinal tuberculosis research (1994-2015): a bibliometric study. Medicine 95:e4923

    Article  Google Scholar 

  15. Sweileh WM (2017) Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015. Orphanet J Rare Dis 12:14

    Article  Google Scholar 

  16. Caldas-Lopes E, Cerchietti L, Ahn JH, Clement CC, Robles AI, Rodina A, Moulick K, Taldone T, Gozman A, Guo Y, Wu N, de Stanchina E, White J, Gross SS, Ma Y, Varticovski L, Melnick A, Chiosis G (2009) Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc Natl Acad Sci U S A 106:8368–8373

    Article  CAS  Google Scholar 

  17. Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Pathology 41:40–47

    Article  Google Scholar 

  18. Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annual Symposium proceedings / AMIA Symposium AMIA Symposium 724–728

  19. Khalil GM, Gotway Crawford CA (2015) A bibliometric analysis of U.S.-based research on the behavioral risk factor surveillance system. Am J Prev Med 48:50–57

    Article  Google Scholar 

  20. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765

    Article  CAS  Google Scholar 

  21. Kanis JA, Cooper C, Rizzoli R, Reginster JY (2018) Review of the guideline of the American College of Physicians on the treatment of osteoporosis. Osteoporos Int 29:1505–1510

    Article  CAS  Google Scholar 

  22. Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. PharmacoEconomics 33:205–224

    Article  Google Scholar 

  23. Reginster JY, Hattersley G, Williams GC, Hu MY, Fitzpatrick LA, Lewiecki EM (2018) Abaloparatide is an effective treatment option for postmenopausal osteoporosis: review of the number needed to treat compared with Teriparatide. Calcif Tissue Int 103:540–545

    Article  CAS  Google Scholar 

  24. Tijssen RJ, Winnink J (2016) Twenty-first century macro-trends in the institutional fabric of science: bibliometric monitoring and analysis. Scientometrics 109:2181–2194

    Article  Google Scholar 

  25. Jin Y, Cui Z, Li X, Jin X, Peng J (2017) Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Oncotarget 8:26090–26099

    PubMed  PubMed Central  Google Scholar 

  26. Cerreta F, Eichler HG, Rasi G (2012) Drug policy for an aging population--the European medicines Agency's geriatric medicines strategy. N Engl J Med 367:1972–1974

    Article  CAS  Google Scholar 

  27. Zhang L, Pang Y, Shi Y, Xu M, Xu X, Zhang J, Ji L, Zhao D (2015) Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Menopause 22:1021–1025

    Article  Google Scholar 

  28. Kim K, Svedbom A, Luo X, Sutradhar S, Kanis JA (2014) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporos Int 25:325–337

    Article  CAS  Google Scholar 

  29. Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwiński E, Krieg MA, Man Z, Mellström D, Radominski SC, Reginster JY, Resch H, Ivorra JAR, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG (2012) Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 27:694–701

    Article  CAS  Google Scholar 

  30. Papapoulos S, Lippuner K, Roux C, Lin CJF, Kendler DL, Lewiecki EM, Brandi ML, Czerwiński E, Franek E, Lakatos P, Mautalen C, Minisola S, Reginster JY, Jensen S, Daizadeh NS, Wang A, Gavin M, Libanati C, Wagman RB, Bone HG (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study. Osteoporos Int 26:2773–2783

    Article  CAS  Google Scholar 

  31. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CAF, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532–1543

    Article  CAS  Google Scholar 

  32. Liu Y, Cao Y, Zhang S, Zhang W, Zhang B, Tang Q, Li Z, Wu J (2018) Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials. Climacteric 21:189–195

    Article  CAS  Google Scholar 

  33. de Villiers TJ, Chines AA, Palacios S, Lips P, Sawicki AZ, Levine AB, Codreanu C, Kelepouris N, Brown JP (2011) Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporos Int 22:567–576

    Article  CAS  Google Scholar 

  34. Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjaerg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD, Bazedoxifene Study G (2012) Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int 23:351–363

    Article  CAS  Google Scholar 

  35. Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, Burnett-Bowie SA, Neer RM, Leder BZ (2013) Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 382:50–56

    Article  CAS  Google Scholar 

  36. Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S (2011) Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis. J Bone Miner Res 26:503–511

    Article  CAS  Google Scholar 

  37. Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T, EUROFORS Investigators (2008) Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res 23:1591–1600

    Article  CAS  Google Scholar 

  38. Doyle N, Varela A, Haile S, Guldberg R, Kostenuik PJ, Ominsky MS, Smith SY, Hattersley G (2018) Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption. Osteoporos Int 29:685–697

    Article  CAS  Google Scholar 

  39. Jin D, Wu X, Yu H, Jiang L, Zhou P, Yao X, Meng J, Wang L, Zhang M, Zhang Y (2018) Systematic analysis of lncRNAs, mRNAs, circRNAs and miRNAs in patients with postmenopausal osteoporosis. Am J Transl Res 10:1498–1510

    PubMed  PubMed Central  Google Scholar 

  40. Li H, Wang Z, Fu Q, Zhang J (2014) Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients. Biomarkers 19:553–556

    Article  CAS  Google Scholar 

  41. Xiong K, Wu T, Fan Q, Chen L, Yan M (2017) Novel reduced graphene oxide/zinc silicate/calcium silicate Electroconductive biocomposite for stimulating osteoporotic bone regeneration. ACS Appl Mater Interfaces 9:44356–44368

    Article  CAS  Google Scholar 

  42. Kochetkova EA, Ugai LG, Maistrovskaia YV, Nevzorova VA (2017) Adipokines: a possible contribution to vascular and bone remodeling in idiopathic pulmonary arterial hypertension. Calcif Tissue Int 100:325–331

    Article  CAS  Google Scholar 

  43. Moradi S, Mirzaei K, Abdurahman AA, Keshavarz SA (2017) Adipokines may mediate the relationship between resting metabolic rates and bone mineral densities in obese women. Osteoporos Int 28:1619–1629

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by Foundation of Changhai Hospital (CH201717); National Natural Science Foundation of China (81701199).

Author information

Author notes

  1. Yuanyu Qiu and Wu Yang contributed equally to this work.

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, The Affiliated Jiangyin Hospital of Southeast University, Jiangyin, China

    Yuanyu Qiu

  2. Department of Orthopedics, The Affiliated Jiangyin Hospital of Southeast University, Jiangyin, China

    Wu Yang

  3. Department of Endocrinology, Changhai Hospital, Second Military Medical University, Shanghai, China

    Qijin Wang

  4. Department of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, China

    Sijia Yan, Bo Li & Xiao Zhai

Authors
  1. Yuanyu Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qijin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sijia Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

X, Z and B, L: conceived and designed the experiments. YY, Q, and W, Y: performed the experiments: QJ, W analyzed the data. YY, Q and SJ, Y: wrote the paper. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yuanyu Qiu, Bo Li or Xiao Zhai.

Ethics declarations

Conflict of interest

None.

Ethical approval and consent to participate

Not applicable.

Consent for publication

Not applicable since the manuscript is entirely original; the tables and figures presented are original for this article and have neither been published nor are currently under consideration for publication by any other journal.

Electronic supplementary material

ESM 1

(XLS 71 kb)

ESM 2

(DOCX 66 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, Y., Yang, W., Wang, Q. et al. Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 13, 121 (2018). https://doi.org/10.1007/s11657-018-0534-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-018-0534-5

Keywords

Search

Navigation